A Study Of Contrast-free Ultrasound Microvessel Imaging In Ocular Tumors

Overview

About this study

The purpose of this study is to determine the feasibility of the new qHDMI biomarkers for differentiation of choroidal melanoma from choroidal nevus.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Aim 1:

Inclusion Criteria:

Female and male volunteer>ages 18 with suspicious eye tumors in their clinical care imaging studies.

Exclusion Criteria:

Having any condition that does not allow proper use of ultrasound scanning
People considered in “vulnerable” populations.

Aim 2:

Inclusion Criteria:

Female and male volunteer>ages 18 with newly diagnosed with choroidal melanoma and are scheduled for radiation/TTT therapy.

Exclusion Criteria:

Having any condition that does not allow proper use of ultrasound scanning
People considered in “vulnerable” populations.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 04/13/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Azra Alizad, M.D.	Open for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Azra Alizad, M.D.

Open for enrollment

More information

Publications

Publications are currently not available

Clinical Trials